NZ207768A - Sustained release tablets comprising dipyridamole - Google Patents

Sustained release tablets comprising dipyridamole

Info

Publication number
NZ207768A
NZ207768A NZ207768A NZ20776884A NZ207768A NZ 207768 A NZ207768 A NZ 207768A NZ 207768 A NZ207768 A NZ 207768A NZ 20776884 A NZ20776884 A NZ 20776884A NZ 207768 A NZ207768 A NZ 207768A
Authority
NZ
New Zealand
Prior art keywords
dipyridamole
tablet
acid
weight
sodium starch
Prior art date
Application number
NZ207768A
Other languages
English (en)
Inventor
J-Y Park
J Debski
K G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of NZ207768A publication Critical patent/NZ207768A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
NZ207768A 1983-04-08 1984-04-06 Sustained release tablets comprising dipyridamole NZ207768A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (1)

Publication Number Publication Date
NZ207768A true NZ207768A (en) 1987-02-20

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ207768A NZ207768A (en) 1983-04-08 1984-04-06 Sustained release tablets comprising dipyridamole

Country Status (20)

Country Link
EP (1) EP0121901B1 (cg-RX-API-DMAC7.html)
JP (1) JPS6034906A (cg-RX-API-DMAC7.html)
KR (1) KR880002139B1 (cg-RX-API-DMAC7.html)
AT (1) ATE32980T1 (cg-RX-API-DMAC7.html)
AU (1) AU570446B2 (cg-RX-API-DMAC7.html)
CA (1) CA1219216A (cg-RX-API-DMAC7.html)
DD (1) DD222496A5 (cg-RX-API-DMAC7.html)
DE (1) DE3469848D1 (cg-RX-API-DMAC7.html)
DK (1) DK166259C (cg-RX-API-DMAC7.html)
ES (1) ES8601687A1 (cg-RX-API-DMAC7.html)
FI (1) FI82604C (cg-RX-API-DMAC7.html)
GR (1) GR81907B (cg-RX-API-DMAC7.html)
HU (1) HU191542B (cg-RX-API-DMAC7.html)
IE (1) IE57220B1 (cg-RX-API-DMAC7.html)
IL (1) IL71458A (cg-RX-API-DMAC7.html)
NO (1) NO164958C (cg-RX-API-DMAC7.html)
NZ (1) NZ207768A (cg-RX-API-DMAC7.html)
PH (1) PH21585A (cg-RX-API-DMAC7.html)
PT (1) PT78380B (cg-RX-API-DMAC7.html)
ZA (1) ZA842562B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
RU2442574C2 (ru) * 2005-08-22 2012-02-20 Новартис Аг ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ pН-ЗАВИСИМОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, МОДИФИКАТОР pН И ЗАМЕДЛЯЮЩИЙ АГЕНТ
SI2101733T1 (sl) 2006-12-13 2012-12-31 F. Hoffmann-La Roche Ag Prašnata formulacija za valganciklovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
ZA842562B (en) 1985-12-24
HUT34345A (en) 1985-03-28
NO841372L (no) 1984-10-09
FI841369A0 (fi) 1984-04-06
PT78380B (en) 1986-08-14
GR81907B (cg-RX-API-DMAC7.html) 1984-12-12
FI841369L (fi) 1984-10-09
NO164958C (no) 1990-12-05
DK166259B (da) 1993-03-29
EP0121901A1 (en) 1984-10-17
DK166259C (da) 1993-08-23
IL71458A0 (en) 1984-07-31
DD222496A5 (de) 1985-05-22
ES531346A0 (es) 1985-11-01
ATE32980T1 (de) 1988-04-15
PT78380A (en) 1984-05-01
IL71458A (en) 1987-09-16
PH21585A (en) 1987-12-11
NO164958B (no) 1990-08-27
JPH0521892B2 (cg-RX-API-DMAC7.html) 1993-03-25
FI82604C (fi) 1991-04-10
ES8601687A1 (es) 1985-11-01
IE840856L (en) 1984-10-08
AU570446B2 (en) 1988-03-17
HU191542B (en) 1987-03-30
JPS6034906A (ja) 1985-02-22
DK181084A (da) 1984-10-09
EP0121901B1 (en) 1988-03-16
AU2660984A (en) 1984-10-11
KR840008588A (ko) 1984-12-17
IE57220B1 (en) 1992-06-03
CA1219216A (en) 1987-03-17
DE3469848D1 (en) 1988-04-21
KR880002139B1 (ko) 1988-10-17
DK181084D0 (da) 1984-04-06
FI82604B (fi) 1990-12-31

Similar Documents

Publication Publication Date Title
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
EP0717986B1 (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally, dextromethorphan
KR890004688B1 (ko) 서방형 약제의 담체 조성물
ES2347968T3 (es) Preparacion solida que se disgrega rapidamente.
FI80829B (fi) Foerfarande foer att framstaella nya orala instatnpreparat av dipyridamol.
CA2182004C (en) Film coated tablet of paracetamol and domperidone
AU1451201A (en) Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
KR20020002321A (ko) 미감이 차폐된 약제학적 입자
CA2601289A1 (en) Once-a-day oxycodone formulations
JP2003534236A (ja) ニメスリドを含む制御放出組成物
US5468503A (en) Oral pharmaceutical preparation released at infragastrointestinal tract
JPH1036269A (ja) 月経困難症及び/又は月経前症候群の軽減用薬剤
AU780379B2 (en) Orally distintegrating composition comprising mirtazapine
EP0121901B1 (en) Ph independent controlled releasable tablets
JP2008081448A (ja) 酒石酸ゾルピデムの苦味マスキング速放性粒子
JPS6024766B2 (ja) 徐放性抗生物質錠